Searchable abstracts of presentations at key conferences in endocrinology

ea0041gp189 | Thyroid - Basic | ECE2016

A new paradigm of TSH receptor signaling in the trans-Golgi network

Godbole Amod , Lyga Sandra , Lohse Martin J , Calebiro Davide

Whereas G-protein coupled receptors (GPCRs) have been long believed to signal through cyclic AMP exclusively at cell surface, our group has previously shown that GPCRs not only signal at the cell surface but can also continue doing so once internalized together with their ligands, leading to persistent cAMP production. This phenomenon, which we originally described for the thyroid stimulating hormone receptor (TSHR) in thyroid cells, has been observed also for other GPCRs. How...

ea0049ep150 | Endocrine tumours and neoplasia | ECE2017

Small pancreatic neuroendocrine incidentalomas: an observational prospective study

Villabona C , Busquets J , Martin L San , Planas A , Pelaez N , Fabregat J , Teule A , Peiro I

Background: Diagnosis of small pancreatic neuroendocrine incidentalomas (PNETs-I) is increasing during last years and often their management remains unclear.Objective: To describe our experience with patients with PNETs-I in our institution.Methods: Since March 2000, patients with non functioning PNETs-I ≤30 mm were evaluated in our center, prospectively. A descriptive analysis of all patients and a comparative study between ...

ea0070aep37 | Adrenal and Cardiovascular Endocrinology | ECE2020

Physiologically based pharmacokinetic modelling to inform dosing in adrenal insufficiency and congenital adrenal hyperplasia

Whitaker Martin J , Bonner Jennifer J , Burt Howard , Johnson Trevor N , Porter John , Ross Richard JM

Background: Replacing physiological cortisol levels is important for the long-term health of patients with adrenal insufficiency and congenital adrenal hyperplasia (CAH). Modified-release formulations of hydrocortisone are one strategy being used to replace the cortisol circadian rhythm in adult patients but there is no data in children. Physiologically based pharmacokinetic (PBPK) modelling is a valuable tool for paediatric drug development1; however, there are no ...

ea0029p1474 | Pituitary Clinical | ICEECE2012

Long-term outcomes after sterotactic radiosurgery for non-functioning pituitary adenomas

Suleiman Y , Vilchez R , Roman A , Soto A , Venegas E , Soto A , Atutxa A , Martin J , Torres E

Introduction: Sterotactic radiosurgery (SR) has been used to treat recurrent adenomas and also as a primary treatment. The objective is to evaluate long-term tumor control, development of hypopituitarism and other side effects in the follow-up.Patients and method: Retrospective analysis of 21 patients with non-functioning pituitary adenomas (NFA) treated with modified linear accelerator (LINAC) between 1998 and 2009 in three tertiary Spanish hospitals. C...

ea0029p1475 | Pituitary Clinical | ICEECE2012

Long-term outcomes after sterotactic radiosurgery for functioning pituitary adenomas

Suleiman Y , Vilchez R , Roman A , Soto A , Venegas E , Leal A , Atutxa A , Martin J , Torres E

Introduction: Sterotactic radiosurgery (SR) has been used to treat recurrent adenomas after failure of medical and surgical procedures and also as a primary treatment. The aim of this paper is to evaluate long-term control of functioning pituitary adenomas (FPA).Patients and method: Thirty-eight patients with FPA treated with modified linear accelerator (LINAC) between 1998 and 2009 in three tertiary Spanish hospitals. Hormonal control was defined as hor...

ea0019p111 | Cytokines and growth factors | SFEBES2009

Glucose does not influence placental regulation of insulin-like growth factor bioavailability during pregnancy

Solomon Alexandra Lubina , Baker Philip N , Gibson J Martin , Aplin John D , Westwood Melissa

Abnormal fetal growth remains a problem in pregnancies, complicated by diabetes and is associated with increased maternal and offspring mortality and morbidity. Insulin-like growth factors (IGFs) are important regulators of fetal growth. Their effects are controlled by binding proteins (IGFBPs). IGFBP-1 is particularly important in pregnancy. Phosphorylated IGFBP-1 (pIGFBP-1) has a high affinity for IGF-I and inhibits IGF-I actions, whereas de-phosphhorylated IGFBP-1 has a low...

ea0015oc7 | Young Endocrinologist prize session | SFEBES2008

Testosterone treatment improves muscle strength, lean mass and quality of life in prefrail and frail elderly men: results from a randomised double-blind placebo-controlled study

Srinivas-Shankar Upendram , Roberts Stephen A , Adams Judith E , Connolly Martin J , Oldham Jackie A , Wu Frederick CW

Introduction: Testosterone (T) improves muscle strength in hypogondal men. It is unclear if testosterone has similar effects in prefrail and frail elderly men with low T. We conducted a randomised double-blind placebo-controlled parallel group study to determine the effects of T on muscle mass and strength, physical function and quality of life in prefrail and frail elderly men.Methods: Two hundred and sixty two prefrail and frail elderly men (Fried e...

ea0013p278 | Steroids | SFEBES2007

Testosterone and frailty in ageing men

Srinivas-Shankar Upendram , Oldham Jackie A , Connolly Martin J , Wu Frederick CW

Introduction: Frailty, a common cause of disability and dependency in the elderly is a multifactorial condition; ageing-associated endocrine dyregulations may play an important role. It is not known if testosterone (T) deficiency contributes to frailty, through its effects on muscle (sarcopenia) and physical function.Objective: To investigate the relationship between T and frailty in elderly men in a cross-sectional observational study in community-dwell...

ea0013p289 | Steroids | SFEBES2007

Is the rate of fall in total testosterone steeper among men in the eighth decade of life?

Srinivas-Shankar Upendram , Oldham Jackie A , Connolly Martin J , Wu Frederick CW

Background: Testosterone (T) levels decline gradually with increasing age in men. However, age-related decline in several functional domains (e.g. frailty, cognitive deficits, osteoporosis) accelerates in the eighth decade. It is not known if the loss of function in the oldest old is related to a more precipitous fall in T.Objective: To determine if total testosterone (TT) declines more rapidly in men in the eighth compared to those in the sixth and seve...

ea0003oc26 | Metabolism | BES2002

Impact of thiazolidinediones on cardiovascular disease risk factors

Marchetti A , Boyle P , King A , Olansky L , Lau H , Magar R , Martin J

Risk of cardiovascular disease is higher for patients with diabetes and dyslipidemia. Known risk factors include elevated triglycerides (TG), total cholesterol (TC), LDL, and low HDL. The log(TG: HDL), known as Atherogenic Index of Plasma (AIP), is inversely correlated with LDL particle size (r=-0.78) and provides another marker of coronary heart disease (CHD) risk. Low-risk CHD cohorts have negative AIP values; high-risk cohorts have positive values. Patients with type 2 diab...